Scheid, C., Sonneveld, P., Schmidt-Wolf, I. G., van der Holt, B., el Jarari, L., Bertsch, U., . . . Lokhorst, H. M. (2014). Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: A subgroup analysis from the HOVON-65/GMMG-HD4 trial. Ferrata Storti Foundation.
Chicago-стиль цитированияScheid, Christof, et al. Bortezomib Before and After Autologous Stem Cell Transplantation Overcomes the Negative Prognostic Impact of Renal Impairment in Newly Diagnosed Multiple Myeloma: A Subgroup Analysis From the HOVON-65/GMMG-HD4 Trial. Ferrata Storti Foundation, 2014.
MLA-цитированиеScheid, Christof, et al. Bortezomib Before and After Autologous Stem Cell Transplantation Overcomes the Negative Prognostic Impact of Renal Impairment in Newly Diagnosed Multiple Myeloma: A Subgroup Analysis From the HOVON-65/GMMG-HD4 Trial. Ferrata Storti Foundation, 2014.